Business Description
Intelgenx Technologies Corp
NAICS : 325412
SIC : 2834
ISIN : US45822R1014
Compare
Compare
Traded in other countries / regions
IGXT.USAIGX.Canada0IL.Germany IPO Date
2016-09-13Description
Intelgenx Technologies Corp is an oral drug delivery company. The company is focused on the development and manufacturing of pharmaceutical oral films based on its proprietary VersaFilmTM technology platform. The company focuses on the development of novel oral immediate-release and controlled-release products for the pharmaceutical market. It offers a comprehensive portfolio of pharmaceutical services, including pharmaceutical R&D, clinical monitoring, regulatory support, tech transfer, and manufacturing scale-up, and commercial manufacturing. Its geographical segments are Europe, Canada, and the United States. The company generates the majority of its revenue from Europe.
Financial Strength
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.15 | |||||
| Equity-to-Asset | -1.48 | |||||
| Debt-to-Equity | -1.27 | |||||
| Debt-to-EBITDA | -2.06 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -16.32 | |||||
| Beneish M-Score | -4.45 | |||||
| WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -24.6 | |||||
| 3-Year EBITDA Growth Rate | 2.9 | |||||
| 3-Year EPS without NRI Growth Rate | 1.4 | |||||
| 3-Year FCF Growth Rate | 11.1 | |||||
| 3-Year Book Growth Rate | -98.1 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 24.9 | |||||
| 9-Day RSI | 36.36 | |||||
| 14-Day RSI | 42.84 | |||||
| 6-1 Month Momentum % | 49.71 | |||||
| 12-1 Month Momentum % | -20.12 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.41 | |||||
| Quick Ratio | 0.4 | |||||
| Cash Ratio | 0.27 | |||||
| Days Inventory | 15.46 | |||||
| Days Sales Outstanding | 226.59 | |||||
| Days Payable | 440.61 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -16.2 | |||||
| Shareholder Yield % | -11.14 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | -66.8 | |||||
| Operating Margin % | -913.47 | |||||
| Net Margin % | -955.44 | |||||
| FCF Margin % | -647.04 | |||||
| ROA % | -113.45 | |||||
| ROIC % | -97.79 | |||||
| ROC (Joel Greenblatt) % | -170.76 | |||||
| ROCE % | -664.05 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 27.5 | |||||
| EV-to-EBIT | -5.04 | |||||
| EV-to-EBITDA | -5.55 | |||||
| EV-to-Revenue | 40.24 | |||||
| EV-to-FCF | -6.27 | |||||
| Price-to-Median-PS-Value | 1.09 | |||||
| Earnings Yield (Greenblatt) % | -19.87 | |||||
| FCF Yield % | -23.45 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Intelgenx Technologies Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 0.963 | ||
| EPS (TTM) (€) | -0.055 | ||
| Beta | 2.58 | ||
| Volatility % | 60.84 | ||
| 14-Day RSI | 42.84 | ||
| 14-Day ATR (€) | 0.014985 | ||
| 20-Day SMA (€) | 0.1459 | ||
| 12-1 Month Momentum % | -20.12 | ||
| 52-Week Range (€) | 0.07 - 0.198 | ||
| Shares Outstanding (Mil) | 174.66 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Intelgenx Technologies Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Intelgenx Technologies Corp Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Intelgenx Technologies Corp Frequently Asked Questions
What is Intelgenx Technologies Corp(STU:0IL)'s stock price today?
The current price of STU:0IL is €0.13. The 52 week high of STU:0IL is €0.20 and 52 week low is €0.07.
When is next earnings date of Intelgenx Technologies Corp(STU:0IL)?
The next earnings date of Intelgenx Technologies Corp(STU:0IL) is 2024-05-10 Est..
Does Intelgenx Technologies Corp(STU:0IL) pay dividends? If so, how much?
Intelgenx Technologies Corp(STU:0IL) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers